Matthew Robson

Ph.D. : West Virginia University Morgantown, WV, 2013 (Pharmaceutical and Pharmacological Sciences)

B.S.: Canisius College Buffalo, NY, 2007 (Biochemistry)

The focus of my laboratory’s research is to understand how traumatic brain injury (TBI) alters neuronal signaling and behavior that is associated with neuropsychiatric disorders including depression and social withdrawal. Chronic changes in psychosocial states, mood and cognition often accompany acute TBI.  TBI results in neuroinflammation and molecular signaling alterations within the brain that have been linked to neuropsychiatric disorders, although the precise mechanisms by which this occurs are still poorly understood. A greater understanding of the molecular underpinnings by which TBI results in neuroinflammation and changes in neural signaling that result in behavioral changes will lead to the identification of drug targets and better medical treatments for those who suffer from TBI.

2004 -2008 Research Assistant, DENT Neurologic Institute,

2013 -2016 Postdoctoral Fellow, Vanderbilt University ,

2016 -2017 Research Assistant Professor, Florida Atlantic University ,

Grant: #NS007491 NIH Role:Trainee Type:Fellowship

Investigators:Robson PhRMA Foundation Role:Investigator Type:Fellowship

Investigators:Robson NARSAD Role:Investigator Active Type:Grant

Grant: #NARSAD Young Investigator Grant 25230 Investigators:Robson, Matthew 01-01-2018 -07-14-2019 Brain & Behavior Research Foundation Regulation of SERT Activity by IL-1R1 Signaling in Serotonergic Neurons Role:PI $47,022.28 Active

Investigators:Robson 2019 -2020 PhRMA Foundation Role of Sigma-1 Receptors in Traumatic Brain Injury Role:PI $100,000 Active Type:Grant

Grant: #PhRMA 2019 Investigators:Robson, Matthew 03-01-2019 -02-28-2020 PhRMA Foundation Role of Sigma-1 Receptors in Traumatic Brain Injury Role:PI $100,000.00 Awarded Level:Private Non-Profit

Grant: #R25081 Investigators:Robson, Matthew 04-01-2019 -03-31-2020 UC's URC Faculty Research Cost Support Awards Program CO2- Induced Slosh Mitigation as a Strategy to Prevent Tramatic Brain Injury Role:PI $7,500.00 Active Level:Internal UC

Grant: #W81XWH-22-1-0849 Investigators:Gardner, Jason; Robson, Matthew 08-01-2022 -07-31-2024 Department of the Army Medical Research Acquisition Activity Targeting IL-1R1 Mediated Anemia in Complex Combat-Related Burns Role:Collaborator 600000.00 Active Level:Federal

Peer Reviewed Publications

Gengo, Fran; Westphal, Erica S; Rainka, Michelle M; Janda, Maria; Robson, Matthew J; Hourihane, J Maurice; Bates, Vernice (2016. ) Platelet response to increased aspirin dose in patients with persistent platelet aggregation while treated with aspirin 81?mg.Journal of clinical pharmacology, , 56 (4 ) ,414-21 More Information

Gengo, Francis M; Rainka, Michelle; Robson, Matthew; Gengo, Michael F; Forrest, Alan; Hourihane, Maurice; Bates, Vernice (2008. ) Prevalence of platelet nonresponsiveness to aspirin in patients treated for secondary stroke prophylaxis and in patients with recurrent ischemic events.Journal of clinical pharmacology, , 48 (3 ) ,335-43 More Information

Lucke-Wold, Brandon P; Turner, Ryan C; Logsdon, Aric F; Nguyen, Linda; Bailes, Julian E; Lee, John M; Robson, Matthew J; Omalu, Bennet I; Huber, Jason D; Rosen, Charles L (2016. ) Endoplasmic reticulum stress implicated in chronic traumatic encephalopathy.Journal of neurosurgery, , 124 (3 ) ,687-702 More Information

Turner, Ryan C; Lucke-Wold, Brandon P; Robson, Matthew J; Lee, John M; Bailes, Julian E (2016. ) Alzheimer's disease and chronic traumatic encephalopathy: Distinct but possibly overlapping disease entities.Brain injury, , 30 (11 ) ,1279-1292 More Information

Lucke-Wold, Brandon P; Naser, Zachary J; Logsdon, Aric F; Turner, Ryan C; Smith, Kelly E; Robson, Matthew J; Bailes, Julian E; Lee, John M; Rosen, Charles L; Huber, Jason D (2015. ) Amelioration of nicotinamide adenine dinucleotide phosphate-oxidase mediated stress reduces cell death after blast-induced traumatic brain injury.Translational research : the journal of laboratory and clinical medicine, , 166 (6 ) ,509-528.e1 More Information

Turner, Ryan C; Lucke-Wold, Brandon P; Logsdon, Aric F; Robson, Matthew J; Lee, John M; Bailes, Julian E; Dashnaw, Matthew L; Huber, Jason D; Petraglia, Anthony L; Rosen, Charles L (2015. ) Modeling Chronic Traumatic Encephalopathy: The Way Forward for Future Discovery.Frontiers in neurology, , 6 ,223 More Information

Turner, Ryan C; Lucke-Wold, Brandon P; Logsdon, Aric F; Robson, Matthew J; Dashnaw, Matthew L; Huang, Jason H; Smith, Kelly E; Huber, Jason D; Rosen, Charles L; Petraglia, Anthony L (2015. ) The Quest to Model Chronic Traumatic Encephalopathy: A Multiple Model and Injury Paradigm Experience.Frontiers in neurology, , 6 ,222 More Information

Nguyen, Linda; Lucke-Wold, Brandon P; Mookerjee, Shona A; Cavendish, John Z; Robson, Matthew J; Scandinaro, Anna L; Matsumoto, Rae R (2015. ) Role of sigma-1 receptors in neurodegenerative diseases.Journal of pharmacological sciences, , 127 (1 ) ,17-29 More Information

Logsdon, Aric Flint; Turner, Ryan Coddington; Lucke-Wold, Brandon Peter; Robson, Matthew James; Naser, Zachary James; Smith, Kelly Elizabeth; Matsumoto, Rae Reiko; Huber, Jason Delwyn; Rosen, Charles Lee (2014. ) Altering endoplasmic reticulum stress in a model of blast-induced traumatic brain injury controls cellular fate and ameliorates neuropsychiatric symptoms.Frontiers in cellular neuroscience, , 8 ,421 More Information

Nguyen, Linda; Kaushal, Nidhi; Robson, Matthew J; Matsumoto, Rae R (2014. ) Sigma receptors as potential therapeutic targets for neuroprotection.European journal of pharmacology, , 743 ,42-7 More Information

Matsumoto, Rae R; Seminerio, Michael J; Turner, Ryan C; Robson, Matthew J; Nguyen, Linda; Miller, Diane B; O'Callaghan, James P (2014. ) Methamphetamine-induced toxicity: an updated review on issues related to hyperthermia.Pharmacology & therapeutics, , 144 (1 ) ,28-40 More Information

Robson, Matthew J; Turner, Ryan C; Naser, Zachary J; McCurdy, Christopher R; O'Callaghan, James P; Huber, Jason D; Matsumoto, Rae R (2014. ) SN79, a sigma receptor antagonist, attenuates methamphetamine-induced astrogliosis through a blockade of OSMR/gp130 signaling and STAT3 phosphorylation.Experimental neurology, , 254 ,180-9 More Information

Nguyen, Linda; Robson, Matthew J; Healy, Jason R; Scandinaro, Anna L; Matsumoto, Rae R (2014. ) Involvement of sigma-1 receptors in the antidepressant-like effects of dextromethorphan.PloS one, , 9 (2 ) ,e89985 More Information

Kaushal, Nidhi; Robson, Matthew J; Rosen, Abagail; McCurdy, Christopher R; Matsumoto, Rae R (2014. ) Neuroprotective targets through which 6-acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79), a sigma receptor ligand, mitigates the effects of methamphetamine in vitro.European journal of pharmacology, , 724 ,193-203 More Information

Matsumoto, Rae R; Nguyen, Linda; Kaushal, Nidhi; Robson, Matthew J (2014. ) Sigma (?) receptors as potential therapeutic targets to mitigate psychostimulant effects.Advances in pharmacology (San Diego, Calif.), , 69 ,323-86 More Information

Turner, Ryan C; Naser, Zachary J; Logsdon, Aric F; DiPasquale, Kenneth H; Jackson, Garrett J; Robson, Matthew J; Gettens, Robert T T; Matsumoto, Rae R; Huber, Jason D; Rosen, Charles L (2013. ) Modeling clinically relevant blast parameters based on scaling principles produces functional & histological deficits in rats.Experimental neurology, , 248 ,520-9 More Information

Robson, Matthew J; Turner, Ryan C; Naser, Zachary J; McCurdy, Christopher R; Huber, Jason D; Matsumoto, Rae R (2013. ) SN79, a sigma receptor ligand, blocks methamphetamine-induced microglial activation and cytokine upregulation.Experimental neurology, , 247 ,134-42 More Information

Kaushal, Nidhi; Seminerio, Michael J; Robson, Matthew J; McCurdy, Christopher R; Matsumoto, Rae R (2013. ) Pharmacological evaluation of SN79, a sigma (?) receptor ligand, against methamphetamine-induced neurotoxicity in vivo.European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, , 23 (8 ) ,960-71 More Information

Turner, Ryan C; Lucke-Wold, Brandon P; Robson, Matthew J; Omalu, Bennet I; Petraglia, Anthony L; Bailes, Julian E (2012. ) Repetitive traumatic brain injury and development of chronic traumatic encephalopathy: a potential role for biomarkers in diagnosis, prognosis, and treatment?.Frontiers in neurology, , 3 ,186 More Information

Robson, Matthew J; Seminerio, Michael J; McCurdy, Christopher R; Coop, Andrew; Matsumoto, Rae R (2013. ) ? Receptor antagonist attenuation of methamphetamine-induced neurotoxicity is correlated to body temperature modulation. Pharmacological reports : PR, , 65 (2 ) ,343-9

Seminerio, Michael J; Robson, Matthew J; McCurdy, Christopher R; Matsumoto, Rae R (2012. ) Sigma receptor antagonists attenuate acute methamphetamine-induced hyperthermia by a mechanism independent of IL-1? mRNA expression in the hypothalamus.European journal of pharmacology, , 691 (1-3 ) ,103-9 More Information

Robson, Matthew J; Elliott, Meenal; Seminerio, Michael J; Matsumoto, Rae R (2012. ) Evaluation of sigma (?) receptors in the antidepressant-like effects of ketamine in vitro and in vivo.European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, , 22 (4 ) ,308-17 More Information

Seminerio, Michael J; Robson, Matthew J; Abdelazeem, Ahmed H; Mesangeau, Christophe; Jamalapuram, Seshulatha; Avery, Bonnie A; McCurdy, Christopher R; Matsumoto, Rae R (2012. ) Synthesis and pharmacological characterization of a novel sigma receptor ligand with improved metabolic stability and antagonistic effects against methamphetamine.The AAPS journal, , 14 (1 ) ,43-51 More Information

Kaushal, Nidhi; Elliott, Meenal; Robson, Matthew J; Iyer, Anand Krishnan V; Rojanasakul, Yon; Coop, Andrew; Matsumoto, Rae R (2012. ) AC927, a ? receptor ligand, blocks methamphetamine-induced release of dopamine and generation of reactive oxygen species in NG108-15 cells.Molecular pharmacology, , 81 (3 ) ,299-308 More Information

Xu, Yan-Tong; Robson, Matthew J; Szeszel-Fedorowicz, Wioletta; Patel, Divyen; Rooney, Robert; McCurdy, Christopher R; Matsumoto, Rae R (2012. ) CM156, a sigma receptor ligand, reverses cocaine-induced place conditioning and transcriptional responses in the brain.Pharmacology, biochemistry, and behavior, , 101 (1 ) ,174-80 More Information

Robson, Matthew J; Noorbakhsh, Bahar; Seminerio, Michael J; Matsumoto, Rae R (2012. ) Sigma-1 receptors: potential targets for the treatment of substance abuse. Current pharmaceutical design, , 18 (7 ) ,902-19

Kaushal, Nidhi; Robson, Matthew J; Vinnakota, Harsha; Narayanan, Sanju; Avery, Bonnie A; McCurdy, Christopher R; Matsumoto, Rae R (2011. ) Synthesis and pharmacological evaluation of 6-acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79), a cocaine antagonist, in rodents.The AAPS journal, , 13 (3 ) ,336-46 More Information

Fishback, James A; Robson, Matthew J; Xu, Yan-Tong; Matsumoto, Rae R (2010. ) Sigma receptors: potential targets for a new class of antidepressant drug.Pharmacology & therapeutics, , 127 (3 ) ,271-82 More Information

Robson, Matthew J; Quinlan, Meagan A; Blakely, Randy D (2017. ) Immune System Activation and Depression: Roles of Serotonin in the Central Nervous System and Periphery.ACS chemical neuroscience, , 8 (5 ) ,932-942 More Information

Robson, Matthew J; Zhu, Chong-Bin; Quinlan, Meagan A; Botschner, David A; Baganz, Nicole L; Lindler, Kathryn M; Thome, Jason G; Hewlett, William A; Blakely, Randy D (2016. ) Generation and Characterization of Mice Expressing a Conditional Allele of the Interleukin-1 Receptor Type 1.PloS one, , 11 (3 ) ,e0150068 More Information

Baganz, N L; Lindler, K M; Zhu, C B; Smith, J T; Robson, M J; Iwamoto, H; Deneris, E S; Hewlett, W A; Blakely, R D (2015. ) A requirement of serotonergic p38? mitogen-activated protein kinase for peripheral immune system activation of CNS serotonin uptake and serotonin-linked behaviors.Translational psychiatry, , 5 ,e671 More Information

Robson, Matthew J; Quinlan, Meagan A; Margolis, Kara Gross; Gajewski-Kurdziel, Paula A; Veenstra-VanderWeele, Jeremy; Gershon, Michael D; Watterson, D Martin; Blakely, Randy D (2018. ) p38a MAPK signaling drives pharmacologically reversible brain and gastrointestinal phenotypes in the SERT Ala56 mouse.Proceedings of the National Academy of Sciences of the United States of America, , More Information

Burke, Susan J; Batdorf, Heidi M; Burk, David H; Martin, Thomas M; Mendoza, Tamra; Stadler, Krisztian; Alami, Wateen; Karlstad, Michael D; Robson, Matthew J; Blakely, Randy D; Mynatt, Randall L; Collier, J Jason (2018. ) Pancreatic deletion of the interleukin-1 receptor disrupts whole body glucose homeostasis and promotes islet B-cell de-differentiation.Molecular metabolism, , More Information

Quinlan, Meagan A; Krout, Danielle; Katamish, Rania; Robson, Matthew J; Nettesheim, Catherine; Gresch, Paul J; Mash, Deborah; Henry, Keith; Blakely, Randy D (2019. ) Human Serotonin Transporter Coding Variation Establishes Conformational Bias with Functional Consequences.ACS chemical neuroscience, , More Information

Liu, Xiaoyu; Nemeth, Daniel P; McKim, Daniel B; Zhu, Ling; DiSabato, Damon J; Berdysz, Olimpia; Gorantla, Gowthami; Oliver, Braedan; Witcher, Kristina G; Wang, Yufen; Negray, Christina E; Vegesna, Rekha S; Sheridan, John F; Godbout, Jonathan P; Robson, Matthew J; Blakely, Randy D; Popovich, Phillip G; Bilbo, Staci D; Quan, Ning (2019. ) Cell-Type-Specific Interleukin 1 Receptor 1 Signaling in the Brain Regulates Distinct Neuroimmune Activities.Immunity, , More Information

231 Albert Sabin Way
Cincinnati  Ohio, 45267-0514
Phone: 513-558-0333
Matthew.Robson@UC.edu

Research - Robson's Lab
231 Albert Sabin Way
Cincinnati  Ohio, 45229
http://pharmacy.uc.edu/research/robson_laboratory